Publications
95
Citations
2,372
Est. group size
~4
Recurring co-author estimate
Active years
18
Publishing since 2009
Typically publishes in teams of ~14 · 16% small-team papers (≤3 authors) · across 11 venues
- Supplementary Table S1 from Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Phase 2 Study
2026
- Data from Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Phase 2 Study
2026
- Brainstem Glioma
2025
- Quantification of the environmental impact of radiotherapy and associated secondary human health effects: a multi-institutional retrospective analysis and simulation
The Lancet Oncology · 2024
- HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES
Cell Reports Medicine · 2024
- The Environmental Impact of Radiation Oncology: The "Footprint" of External Beam Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics · 2023
- Phase II, double-blind, randomized study of salvage radiation therapy (SRT) plus enzalutamide or placebo for high-risk PSA-recurrent prostate cancer after radical prostatectomy: The SALV-ENZA Trial.
Journal of Clinical Oncology · 2022
- The association of germline<i> HSD3B1</i> genotype with outcomes in metastatic hormone-sensitive prostate cancer (mHSPC) treated with androgen deprivation therapy (ADT) with or without enzalutamide (ENZA) [ARCHES].
Journal of Clinical Oncology · 2022
- Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy
European Urology Oncology · 2021
- Megavolt bremsstrahlung measurements from linear induction accelerators demonstrate possible use as a FLASH radiotherapy source to reduce acute toxicity
Scientific Reports · 2021
- Essentials of Clinical Radiation Oncology
2021
- Interim results of aasur: A single arm, multi-center phase 2 trial of apalutamide (A) + abiraterone acetate + prednisone (AA+P) + leuprolide with stereotactic ultra-hypofractionated radiation (UHRT) in very high risk (VHR), node negative (N0) prostate cancer (PCa).
Journal of Clinical Oncology · 2021
- Brainstem Glioma
2021
- Megavolt Bremsstrahlung Measurements from Linear Induction Accelerators Demonstrate Possible Use as a FLASH Radiotherapy Source to Reduce Acute Toxicity
Research Square · 2021
- <i>HSD3B1</i> Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer
JAMA Oncology · 2020
- International Journal of Radiation Oncology*Biology*Physics×22
- Journal of Clinical Oncology×18
- JAMA Oncology×4
- The Journal of Urology×3
- The Lancet Oncology×2
- Matthew McFarlane
Medicine · University of Michigan
- Skyler B. Johnson
Medicine · Indiana University
- John D. Graham
Medicine · Indiana University
- Ralph Jiang
Medicine · University of Michigan
- Zachary Reichert
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile